GLP-1 Medical Evaluation: What to Expect During Your Assessment

If you've decided to explore GLP-1 medication for weight loss, the medical evaluation is your first real step. Whether it happens in a doctor's office or through a telehealth screen, the process follows a clinical framework designed to determine your eligibility, establish safety parameters, and build a treatment plan tailored to your body.

Here's what actually happens during that evaluation — and what to expect at each stage.

Step 1: Health History Intake

Every evaluation begins with a comprehensive health questionnaire. You'll be asked about:

• Current weight, height, and weight history (including previous diets or weight-loss attempts)
• Existing diagnoses — diabetes, hypertension, PCOS, sleep apnea, thyroid conditions
• Surgical history — particularly bariatric procedures or gastrointestinal surgeries
• Family history of thyroid cancer, pancreatitis, or cardiovascular disease
• Current medications and supplements
• Allergies and prior adverse drug reactions

On telehealth platforms, this is typically a structured digital questionnaire completed before your provider review. In-person visits may cover the same ground through conversation.

Step 2: Clinical Review by a Licensed Provider

A physician, nurse practitioner, or physician assistant reviews your intake. They're looking for three things:

• Eligibility: Do you meet BMI criteria (≥30, or ≥27 with comorbidities)?
• Safety: Are there any contraindications that make GLP-1 therapy risky for you?
• Appropriateness: Is pharmacotherapy the right next step given your history and goals?

Good providers don't just check boxes — they evaluate the whole picture. Someone with a BMI of 31 but active bulimia needs eating disorder treatment before GLP-1 therapy, not a prescription.

Step 3: Lab Work (When Required)

Depending on your health profile, your provider may order or request recent lab results. Common panels include metabolic markers (fasting glucose, HbA1c), kidney function, liver enzymes, and thyroid levels. Some telehealth platforms accept labs from your primary care physician; others have partnerships with national lab networks.

Step 4: Medication Selection and Dosing

Once cleared, your provider selects the appropriate GLP-1 medication and starting dose. Key decisions include:

• Semaglutide vs. tirzepatide — based on your metabolic profile, prior medication trials, and cost considerations.
• Starting dose — typically 0.25mg semaglutide or 2.5mg tirzepatide weekly, with planned titration over several months.
• Compounded vs. brand-name — depending on availability, cost, and provider formulary.

Step 5: Treatment Plan and Follow-Up Schedule

A complete evaluation ends with a documented treatment plan: your medication, dosing schedule, titration timeline, side-effect management strategies, and follow-up appointments. Most providers schedule a check-in at 4–6 weeks to assess tolerability and adjust dosing.

The evaluation process should feel thorough, not rushed. If your provider spent more time on payment processing than medical questions, consider that a signal to look elsewhere.